No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Pyrotinib plus capecitabine improves progression-free survival in HER2⁺ metastatic breast cancer

byTeddy Guo

March 10, 2021

in StudyGraphics

Reading Time: 1 min read

Combined division of the splenic vein a safe method for distal pancreatectomy

RelatedReports

3D mammography (tomosynthesis) enhances accuracy of breast cancer screening

Oncology

Sentinel lymph node biopsy may reduce the need for axillary dissection in cN1 breast cancer

May 20, 2026

Development of a risk index for colorectal cancer screening

Chronic Disease

Sequential compared to upfront treatment of metastatic colorectal cancer using oxaliplatin (Eloxatin) therapy may lead to similar outcomes

May 12, 2026

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs

Chronic Disease

The incidence of early-onset metastatic adenocarcinoma may be higher among patients with multiple metastatic sites and peritoneal involvement

April 30, 2026

Thoracic radiotherapy improves survival in small-cell lung cancer patients

Chronic Disease

Simvastatin (Zocor) in combination with paclitaxel (Taxol) may provide treatment benefit compared to paclitaxel alone for small cell lung cancer

April 15, 2026

RTS,SA/S01 anti-malarial vaccine efficacy wanes significantly over time

Targeted indoor residual spraying (IRS) is non-inferior to standard IRS for malaria control and in low-transmission settings

#VisualAbstract: Tocilizumab reduced COVID-19 disease related adverse health outcomes

#VisualAbstract: Cabozantinib improves progression-free survival in patients with metastatic papillary renal cell carcinoma

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Using the C2HEST score to identify at‐risk patients for sustained atrial high‐rate episodes

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Pyrotinib plus capecitabine improves progression-free survival in HER2⁺ metastatic breast cancer

RELATED REPORTS

Combined division of the splenic vein a safe method for distal pancreatectomy

Targeted indoor residual spraying (IRS) is non-inferior to standard IRS for malaria control and in low-transmission settings

RelatedReports

Recent Reports